Acetylsalicylic acid Not Yet Recruiting Phase 2 Trials for Nasopharyngeal Carcinoma Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03290820Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients